JPX · 4570.T
Immuno-Biological Laboratories Co., Ltd.
¥1,027-¥12 (-1.15%)
Immuno-Biological Laboratories Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 73.12% below the high.
Loading market information…
JPX · 7091.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Living Platform,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Living Platform,Ltd.’s forward annual dividend is ¥5 per share, paid annual. The forward yield is 0.42% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Living Platform,Ltd.’s next earnings report is currently expected on Nov 18, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Living Platform,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2011, Living Platform,Ltd. is a company based in Sapporo, Japan, that provides a range of services encompassing nursing care, childcare, and assistance for individuals with disabilities.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:02 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,027-¥12 (-1.15%)
Immuno-Biological Laboratories Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 73.12% below the high.
¥391-¥1 (-0.26%)
Care Twentyone Corporation’s quoted price sits in the lower half of its reported 52-week range, 21.49% below the high.
¥800+¥3 (+0.38%)
teno. Holdings Company Limited’s quoted price sits in the lower half of its reported 52-week range, 18.86% below the high.
¥591+¥4 (+0.68%)
Human Metabolome Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.85% below the high.
¥1,308+¥8 (+0.62%)
FB Care Service Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 4.53% below the high.
¥1,123-¥2 (-0.18%)
Miahelsa Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 6.42% below the high.
¥142+¥2 (+1.43%)
Perseus Proteomics Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.24% below the high.
¥658-¥4 (-0.6%)
Care Service Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.36% below the high.
